Oruka Therapeutics Investigative Site

Edmonton, Alberta T6G 1C3

2 studies enrolling now · 3 studies all time

What they study most

Plaque Psoriasis

Studies at this site

• An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis — Recruiting now
• Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis — Recruiting now
• ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis — Running, not enrolling